| 내 용 |
I can"t hear you very well http://12yo.icu 12yo nn Large pharmaceutical and biotech companies have been looking to acquire smaller biotech firms to gain access to new drugs and offset revenue losses stemming from expired patents, but rich valuations of target companies are proving to be a big hurdle to dealmaking.
|
